These 40 Mass. firms made the new Deloitte Fast 500 list
The list, released on Wednesday, ranks the fastest-growing technology, media, telecommunications and life sciences companies based in North America.
- Supported exchanges /
- NASDAQ /
- PULM.NASDAQ
Pulmatrix Inc (PULM NASDAQ) stock market data APIs
$1.86
-0.15(-7.5%)
as of September 13, 2024
Price chart is built with Anychart
Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.
Pulmatrix Inc Financial Data Overview
| 2.01 | |
| 1.86 | |
| - | |
| 2.0164 | |
| 1.8 | |
| 1.55-2.7499 | |
| 7 341 K | |
| 3 652 K | |
| 11 392 K | |
| -1.5911 | |
| 0.997 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'PULM',
Type:
'Common Stock',
Name:
'Pulmatrix Inc',
Exchange:
'NASDAQ',
CurrencyCode:
'USD',
CurrencyName:
'US Dollar',
CurrencySymbol:
'$',
CountryName:
'USA',
CountryISO:
'US',
OpenFigi:
'BBG003TH2QL1',
ISIN:
NULL,
CUSIP:
NULL,
CIK:
'1574235',
EmployerIdNumber:
'46-1821392',
FiscalYearEnd:
'December',
IPODate:
'2014-03-21',
InternationalDomestic:
'Domestic',
Sector:
'Healthcare',
Industry:
'Biotechnology',
HomeCategory:
'Domestic',
IsDelisted:
false,
}
Pulmatrix Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 11 392 K
- EBITDA -11 142 000
- Earnings Per Share -2.98
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Pulmatrix Inc Earnings via APIs
- Latest Release 2024-08-13
- EPS/Forecast NaN
Get Pulmatrix Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get Pulmatrix Inc latest news via APIs
These 40 Mass. companies made the new Deloitte Fast 500 list
The list, released Wednesday, ranks the fastest-growing technology, media, telecommunications and life sciences companies based in North America.
- DELOITTE
- LIFE SCIENCES COMPANIES
- TECHNOLOGY FAST 500 RANKING
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
